Eli Lilly And Co vs Waste Management, Inc. — how do they compare? Eli Lilly And Co trades at $1,179.27 (market cap $1.04T), while Waste Management, Inc. trades at $208.83 (market cap $83.98B). The key difference: Eli Lilly And Co is far larger — about 12.4× Waste Management, Inc.'s market cap, and Waste Management, Inc. pays the higher dividend (1.8%). Which is the better fit depends on your goals — on Pluang, investors hold Eli Lilly And Co for 93 Days and Waste Management, Inc. for 130 Days on average.
| LLY | WM | |
|---|---|---|
Market Cap | $1.04T | $83.98B |
Volume | 3,064,878 | 2,182,180 |
Sector | Health | Industrials |
52-Week High | $1.28K | $246.51 |
52-Week Low | $799.57 | $196.77 |
Typical Hold Time | 93 Days | 130 Days |
Enterprise Value | $1.09T | $106.78B |
Dividend Yield | 0.59% | 1.8% |
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,169.93, down 1.58% on the day, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The company's weight-loss drug portfolio continues to drive exceptional performance, with Q2 2026 EPS of $8.38 beating expectations by 31%. Technical indicators show bullish moving averages while fundamentals reveal impressive 83.4% gross margins and 102.44% ROE. Recent clinical trial successes for next-generation obesity treatments position Lilly for continued market leadership.
LLY presents a compelling growth story with dominant positioning in the expanding obesity/diabetes market, though elevated valuations (P/E 39.26) and regulatory risks require monitoring. Analyst consensus remains strongly bullish with $1,350 price target representing 15% upside. The primary investment thesis centers on pipeline execution and market expansion opportunities, balanced against competitive pressures and valuation concerns.
WM trades at $210.10, up 0.56% today, with a bullish technical signal and strong profitability metrics including a 29.83% ROE. Recent earnings have mostly beaten expectations, and the company maintains a solid dividend. Revenue grew to $25.20 billion in 2025, though net income margin dipped to 10.74%. Analyst consensus is strongly positive with no sell ratings.
The outlook for WM is favorable due to consistent cash flow, pricing power, and strategic acquisitions. Risks include elevated debt levels and sensitivity to economic cycles. With a P/E of 29.72, the stock is priced for growth, supported by bullish analyst sentiment and defensive business model strengths.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
Read more on WM →